AIP
QTTB icon

Ameritas Investment Partners’s Q32 Bio QTTB Stock Holding History

Ameritas Investment Partners’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-591
Closed -$975 – 3373
2025
Q1 		$975 Hold
591
– – ﹤0.01% 3105
2024
Q4 		$2.03K Hold
591
– – ﹤0.01% 3099
2024
Q3 		$26.4K Hold
591
– – ﹤0.01% 2515
2024
Q2 		$10.6K Buy
+591
New +$14.1K ﹤0.01% 2902
2022
Q2 		– Sell
-167
Closed -$9K – 3260
2022
Q1 		$9K Hold
167
– – ﹤0.01% 2843
2021
Q4 		$11K Hold
167
– – ﹤0.01% 2880
2021
Q3 		$24K Hold
167
– – ﹤0.01% 2609
2021
Q2 		$22K Hold
167
– – ﹤0.01% 2697
2021
Q1 		$28K Hold
167
– – ﹤0.01% 2415
2020
Q4 		$34K Hold
167
– – ﹤0.01% 2213
2020
Q3 		$32K Hold
167
– – ﹤0.01% 2126
2020
Q2 		$46K Buy
167
+51
+44% +$13.6K ﹤0.01% 1886
2020
Q1 		$32K Hold
116
– – ﹤0.01% 1915
2019
Q4 		$43K Hold
116
– – ﹤0.01% 2014
2019
Q3 		$38K Hold
116
– – ﹤0.01% 2040
2019
Q2 		$41K Buy
116
+37
+47% +$14.5K ﹤0.01% 2030
2019
Q1 		$39K Buy
79
+31
+65% +$13.9K ﹤0.01% 2032
2018
Q4 		$19K Hold
48
– – ﹤0.01% 2376
2018
Q3 		$20K Hold
48
– – ﹤0.01% 2516
2018
Q2 		$18K Buy
+48
New +$17.2K ﹤0.01% 2572

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameritas Investment Partners's QTTB Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Q32 Bio (QTTB) in Q2 2025, closing a stake of 591 shares — an estimated $975 sold.

Ameritas Investment Partners first reported a position in QTTB in Q2 2018 and held it in 20 quarters. The position peaked at $46K in Q2 2020. 61 funds tracked by Wall St. Rank hold QTTB as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Q32 Bio position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 591 Q32 Bio shares in Q2 2025, an estimated $975.
  • Ameritas Investment Partners first reported a position in Q32 Bio in Q2 2018 and held it in 20 quarters.
  • Ameritas Investment Partners's Q32 Bio position peaked at $46K in Q2 2020.
  • 61 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.